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A SWI/SNF±Related Chromatin Remodeling Complex,
E-RC1, Is Required for Tissue-Specific
Transcriptional Regulation by EKLF In Vitro
with an activator to stimulate transcription from a chro-
matin-assembled template in vitro (Ito et al., 1997; Mizu-
guchi et al., 1997).
Among the chromatin remodeling complexes, yeast
SWI/SNF was the first to be identified. Genetic studies
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²Mt. Sinai School of Medicine revealed that SWI/SNF is required for the transcription
of a subset of genes including HO, SUC2, ADH1, ADH2,Brookdale Center for Molecular Biology
New York, New York 10029 GAL1, and GAL10. Suppressors of SWI/SNF mutations
were identified as histones, indicating that the SWI/SNF
complex functions to counteract the repressive effects
of chromatin on transcription (reviewed in Winston andSummary
Carlson, 1992). Indeed, both yeast and human SWI/SNF
complexes function in vitro to disrupt chromatin struc-Erythroid KruÈ ppel-like factor (EKLF) is necessary for
ture and facilitate factor binding (CoÃ teÂ et al., 1994; Imbal-stage-specific expression of the human b-globin gene.
zano et al., 1994; Kwon et al., 1994). Multiple mammalianWe show that EKLF requires a SWI/SNF±related chro-
SWI/SNF complexes (BAF complexes) have been identi-matin remodeling complex, EKLF coactivator-remod-
fied and shown to be diverse in subunit compositioneling complex 1 (E-RC1), to generate a DNase I hyper-
(Wang et al., 1996a, 1996b, 1998). The mammalian SWI/sensitive, transcriptionally active b-globin promoter
SNF (BAF) complexes contain either BRG1 or humanon chromatin templates in vitro. E-RC1 contains BRG1,
brahma (hbrm). These ATPases are homologous to theBAF170, BAF155, and INI1 (BAF47) homologs of yeast
yeast protein SWI2/SNF2 (Khavari et al., 1993; MuchardtSWI/SNF subunits, as well as a subunit unique to
and Yaniv, 1993). BAF155 (BRG1-associated factor, 155higher eukaryotes, BAF57, which is critical for chroma-
kDa) and BAF170 are both homologs of yeast SWI3.tin remodeling and transcription with EKLF. E-RC1
Interestingly, subunits unique to SWI/SNF±like com-displays functional selectivity toward transcription
plexes of higher eukaryotes are now being identified.factors, since it cannot activate expression of chroma-
For example, BAF57 is found in mammalian complexestin-assembled HIV-1 templates with the E box±binding
(Wang et al., 1998), and its counterpart, BAP111, wasprotein TFE-3. Thus, a member of the SWI/SNF family
identified in the Drosophila SWI/SNF±related complexacts directly in transcriptional activation and may reg-
(Papoulas et al., 1998). These subunits both contain anulate subsets of genes by selectively interacting with
HMG-like domain, and no such subunits are found inspecific DNA-binding proteins.
the yeast complexes.
To examine how chromatin structure is modified to
Introduction allow transcription of a tissue-specific, developmentally
regulated gene, we have chosen the human b-globin
Cell type±specific transcriptional activators and repres-
promoter as a model system. The b-globin locus is well
sors play a critical role in controlling gene expression
characterized, consisting of an upstream locus control
that ultimately results in tissue differentiation and spe-
region (LCR) followed by five genes (59-e, Gg, Ag, d, b-39)
cialization. In the cell, transcription factors must work
arranged in the order of their developmental expression.
within and around the confines of chromatin. The basic
The open chromatin configuration of the b-globin locus
unit of chromatin is the nucleosome, 146 base pairs of
in expressing erythroid cells is DNase I sensitive withDNA wrapped almost two turns around a histone oc-
active promoters showing hypersensitivity (Groudine ettamer (Luger et al., 1997). The structure of chromatin
al., 1983). DNA-binding sites for erythroid-restricteditself provides one important level of gene regulation, as
transcription factors are concentrated in the LCR anddemonstrated by the observation that transcriptionally
individual gene promoters and enhancers. These pro-active genes are characterized by an open chromatin
tein-binding motifs include sites for the erythroid factorsstructure, whereas inactive genes are packaged in a
GATA-1, NF-E2, and EKLF (reviewed in Baron, 1997).highly condensed chromatin configuration (Weintraub
Of these factors, EKLF is a key regulator of b-globinand Groudine, 1976).
expression. Transgenic mice that lack EKLF die of ane-Several chromatin remodeling complexes have re-
mia at the developmental stage when the adult form ofcently been described. These include SWI/SNF, RSC,
b-globin is normally expressed (Nuez et al., 1995; Per-NURF, CHRAC, ACF, and FACT (reviewed in Pazin and
kins et al., 1995). In these mice, the b-globin promoterKadonaga, 1997; Armstrong and Emerson, 1998; Cairns,
remains in a closed chromatin configuration (no hyper-1998; Kadonaga, 1998). With the exception of FACT, all
sensitivity), yet expression of early globin genes is nor-the complexes contain an ATPase activity required for
mal, indicating that EKLF is a true stage-specific regula-nucleosome disruption or remodeling. Thus far, only
tor of the adult b-globin gene (Wijgerde et al., 1996).ACF and NURF have been shown to function in concert
EKLF expression is restricted to the normal sites of
hematopoiesis. It contains a proline-rich activation do-
main at the amino terminus and three TFIIIA-like zinc³ To whom correspondence should be addressed (e-mail: emerson@
salk.edu). fingers within the carboxyl terminus (Miller and Bieker,
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Figure 1. Transcriptional Activation of Chromatin-Assembled b-Globin Template Requires Both EKLF and a Coactivator, E-RC1
(A) Transcription of chromatin-reconstituted b-globin template. Glycerol gradient fraction or DNA±cellulose fraction containing the EKLF
coactivator E-RC1 and recombinant purified EKLF protein were added to 1 mg chromatin as indicated. Relative fold activation is shown
below each lane. Quantitation was performed using a Molecular Dynamics phosphorimager. Fold transcription activation was determined by
subtracting a background value for each lane from both b-globin and AdLuc signals. The control AdLuc signal for lane 2 was set at one and
the relative AdLuc values were divided into the appropriate b-globin signal. Repressed b-globin transcription (lane 2) was then set at one.
Primer extension products are marked by arrows. M, MspI-digested pBR322 as a molecular weight marker.
(B) EKLF and the coactivator E-RC1 have no effect on transcription of free DNA. b-globin template (250 ng) was incubated with 2.5 ml
DNA±cellulose fraction containing E-RC1 and/or 9.3 pmol EKLF, as indicated, and transcribed as described for the chromatin templates in
Experimental Procedures. Relative fold transcriptional activation is shown under each lane. M, MspI-digested pBR322 as a molecular weight
marker.
(C) Experimental flowchart. See Experimental Procedures for detailed protocols.
1993). EKLF was the founding member of the KruÈ ppel- using an in vitro chromatin assembly system. We show
that EKLF requires a coactivator to form a transcription-like factor family, named as such because the zinc fin-
gers possess a high degree of similarity to the Drosoph- ally competent b-globin promoter by structurally remod-
eling repressed chromatin in an ATP-dependent man-ila gap gene KruÈ ppel. Other members of this new family
include LKLF (lung KruÈ ppel-like factor), found predomi- ner. We identify the coactivator E-RC1 as a member of
the mammalian SWI/SNF family of chromatin remodel-nantly in lung and spleen (Anderson et al., 1995); BKLF
(basic KruÈ ppel-like factor), highly expressed in the mouse ing complexes. Although E-RC1 has general chromatin
disruption activity, it is unable to activate transcrip-embryonic midbrain (Crossley et al., 1996); and GKLF
(gut-enriched KruÈ ppel-like factor), an epithelial-specific tion in combination with another DNA-binding protein,
TFE-3, on the chromatin-assembled human immunode-factor associated with growth arrest (Shields et al.,
1996). EKLF regulates the human b-globin promoter ficiency virus-1 (HIV-1) promoter. Thus, E-RC1 displays
selectivity toward EKLF and demonstrates potentialthrough the 290 CACCC sequence. Naturally occurring
mutations within this CACCC box result in b-thalesse- functional diversity among members of the mammalian
SWI/SNF family.mias in humans (Orkin et al., 1982; Kulozik et al., 1991),
caused by reduced levels of b-globin expression due
to decreased DNA binding and transcriptional activation Results
by EKLF (Feng et al., 1994). Thus, EKLF is unquestion-
ably critical for stage-specific expression of the b-globin Transcription from the Chromatin-Reconstituted
Human b-Globin Promoter Depends upongene (Donze et al., 1995).
To understand the mechanism of action of this key EKLF and a Coactivator, E-RC1
Plasmids containing the intact b-globin promoter fromerythroid regulator, we have reproduced EKLF-medi-
ated transcriptional activation of the b-globin promoter 2385 to 118, linked to the CAT gene, were assembled
b-Globin Chromatin Activation by EKLF and E-RC1
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Figure 2. The Chromatin Structure of the b-Globin Promoter Is Disrupted Prior to Transcription and This Structural Change Is ATP Dependent
(A) Hypersensitive site formation occurs only in the presence of both EKLF and E-RC1. After assembly, chromatin was incubated with
DNA±cellulose E-RC1 fraction and/or EKLF as indicated. The chromatin reactions were then split, and one-half was transcribed as a control
(data not shown). Remaining chromatin was divided into three tubes (100 ng chromatin per tube) and digested with DNase I for 1 min at 278
C. Triangles indicate increasing amounts of DNase I. Free DNA was digested with 0, 0.0015, 0.0045, or 0.0135 U DNase I (3.1 U/mg). Chromatin
reactions were digested with 0, 0.3, 0.9, or 2.7 U DNase I. Following purification, DNA was digested with NcoI. The indirect end-labeling
procedure is described in Experimental Procedures. Brackets indicate the promoter region from 2120 to 110. M, b-globin plasmid digestions
used as molecular weight markers. Bands represent digests of NcoI (4.7 kb), NcoI/BsaAI (841 bp), and NcoI/EcoRI (301 bp).
(B) The DNase I hypersensitive site is abolished in the presence of apyrase. After assembly, 1 mg chromatin was incubated with either buffer
or 0.2 U apyrase as indicated at 278C for 10 min. Reactions were then incubated with DNA±cellulose E-RC1 fraction and/or EKLF as indicated.
Chromatin was divided into six tubes with 150 ng chromatin per tube and digested with 0, 0.9, 1.2, 1.5, 1.8, or 2.1 U DNase I. Triangles indicate
increasing amounts of enzyme. Brackets show 2120 to 110 of the promoter region. M, molecular weight markers as described in Figure
legend 2A.
into chromatin using Drosophila embryonic extracts The reconstituted chromatin templates used in these
experiments contain evenly spaced nucleosomes, as(Bulger and Kadonaga, 1994). As expected, chromatin-
assembled templates are transcriptionally repressed determined by micrococcal nuclease analysis, and the
bulk chromatin structure is unaffected by the addition(Figure 1A, lane 2). We initially examined whether binding
of the erythroid-specific transcriptional activator EKLF of EKLF and E-RC1 (data not shown). EKLF and E-RC1
are added after nucleosome assembly is complete (asto the 290 CACCC box in the human b-globin promoter
could generate an open chromatin structure and allow diagrammed in Figure 1C), suggesting that an active
chromatin remodeling process is occurring. Moreover,transcription to occur. These experiments indicated that
EKLF alone could not efficiently activate b-globin ex- EKLF and E-RC1 are unable to stimulate transcription
of free DNA (Figure 1B), indicating that they functionpression (lane 5), which led us to search for a possible
coactivator of EKLF function. Chromatographic fraction- specifically through chromatin structure.
ation of protein extracts from mouse erythroleukemia
(MEL) cells, which represent the definitive erythroid lin- Chromatin Structural Remodeling of the b-Globin
Promoter Requires Both EKLF and E-RC1eage and express high levels of endogenous b-globin
genes, resulted in the purification of an activity, EKLF To examine the nucleosomal structure of in vitro±assem-
bled b-globin promoters, indirect end-labeling analysiscoactivator-remodeling complex 1 (please see Figure
4C for an SDS-PAGE analysis of purified E-RC1). This of DNase I digested chromatin was performed. Impor-
tantly, these digestions were carried out prior to tran-complex functioned with EKLF to activate chromatin-
assembled b-globin promoters (lanes 4 and 6), yet was scription and thus reflect potentially active, rather than
transcribing, promoters. A DNase I hypersensitive re-insufficient by itself (lanes 3 and 7). Additionally, neither
EKLF nor E-RC1 could individually activate transcription gion from approximately 2120 to 110 in the b-globin
promoter was observed in the presence of both EKLFwhen bound to the DNA template prior to chromatin
formation (data not shown). and E-RC1 (Figure 2A, lane 15). This pattern resembles
Cell
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Figure 3. E-RC1 Cannot Function with TFE-3
to Activate Transcription of Chromatin-
Assembled HIV-1 Templates
Transcriptional activation of chromatin-recon-
stituted HIV-1 template. The plasmid tem-
plate was assembled into chromatin in the
presence (lanes 3±8) or absence (lanes 1, 2,
9±16) of purified TFE-3. Following assembly,
the DNA±cellulose fraction of E-RC1 (2.5 ml,
lanes 5 and 6 and 9 and 10; or 5 ml, lanes 7
and 8, 11 and 12, 15 and 16) and TFE-3 (lanes
13±16) were added to 100 ng of HIV-1 tem-
plate and incubated for 10 min at room tem-
perature. Transcription proceeded following
the addition of a nuclear HeLa extract and incubation at 308C for 30 min. Primer extension products of the HIV-1 promoter and the a-globin
internal control are indicated by arrows.
the hypersensitive structure of the active b-globin pro- The EKLF Coactivator E-RC1 Is Identified as a Member
of the Mammalian SWI/SNF Family of Chromatinmoter in vivo which maps from 100±150 bp 59 of the
cap site (Groudine et al., 1983). Neither EKLF (lanes Remodeling Complexes
E-RC1 was purified according to the scheme shown in17±19) nor E-RC1 (lanes 10±12) were sufficient alone to
generate an open chromatin configuration. Since most Figure 4A. By glycerol gradient sedimentation, E-RC1
was identified as a large 18.7S multiprotein complexchromatin remodeling events are energy-dependent, we
asked whether hypersensitive site formation in the that cofractionates with known mammalian SWI/SNF
subunits. When fractions across the 20%±35% glycerolb-globin promoter was dependent on ATP. Chromatin
templates were incubated with the ATP-hydrolyzing re- gradient were assayed, transcriptional activity peaked
in fractions 4 and 5 (Figure 4B, lanes 7 and 8), as didagent apyrase prior to addition of EKLF and E-RC1.
Indeed, formation of the open b-globin promoter struc- DNase I hypersensitive site formation (data not shown).
An SDS-PAGE analysis shows the purity and proteinture by these proteins requires ATP (Figure 2B, compare
subunit composition of these fractions (Figure 4C).lanes 8±12 to 14±18).
Western blot analyses using antibodies to mammalian
SWI/SNF subunits were conducted on the same glycerol
E-RC1 Displays Functional Selectivity for EKLF gradient fractions (Figure 4D). The subunits BAF155,
To analyze the specificity of E-RC1 as a coactivator BAF57, and BRG1 all comigrate with the transcriptional
of EKLF, we examined whether it could function with activity in fractions 4 and 5. Moreover, BAF170 and INI1
another protein, TFE-3, to facilitate transcription from (BAF47) proteins also peak in these fractions (data not
the HIV-1 promoter. TFE-3 is a member of the helix- shown). Interestingly, BRG1 protein is found in a second
loop-helix family of DNA-binding proteins and interacts peak (fractions 7 and 8) that does not support b-globin
with an E box motif at 2177 within the HIV-1 enhancer. transcription, suggesting that other BRG1-containing
Recombinant TFE-3 and other HIV-1 enhancer±binding complexes with different functions may exist. E-RC1
proteins have been shown to activate efficiently tran- cofractionated with the core SWI/SNF subunits BAF57,
scription of a chromatin-assembled HIV-1 template in BAF155, and BRG1 through each of the three column
vitro (Sheridan et al., 1995). As shown in Figure 3, pre- steps (data not shown) and may represent a major SWI/
binding of TFE-3 alone to HIV-1 DNA followed by chro- SNF activity in MEL cells. A small amount of RNA poly-
matin assembly with Drosophila embryo extracts gener- merase II was present in the DNA±cellulose fraction, as
ates a structure that is active for transcription in vitro detected by Western blot analysis using an antibody to
(lanes 3 and 4) relative to chromatin-repressed tem- the CTD. However, after the glycerol gradient step, RNA
plates lacking prebound TFE-3 (lanes 1 and 2). Addition polymerase II was only detectable in fraction 8 and,
of E-RC1 to TFE-3-bound HIV-1 chromatin failed to thus, did not comigrate with the EKLF-dependent E-RC1
appreciably increase transcription (lanes 5±8). When coactivator (data not shown). All antibodies to mamma-
E-RC1 was analyzed for its ability to facilitate TFE-3 bind- lian SWI/SNF subunits tested so far have comigrated
ing to assembled chromatin (postbinding), as b-globin with this transcriptional activity. Although E-RC1 was
activation by EKLF is normally assayed, no transcription originally purified from erythroid cells, it may not be
occurred with (lanes 15 and 16) or without E-RC1 (lanes tissue-restricted. A partially purified E-RC1 fraction from
13 and 14). Thus, E-RC1 displays functional selectivity HeLa cells also displays EKLF coactivator activity.
for EKLF, as it is not a coactivator of TFE-3. These results To determine whether purified E-RC1 displays classi-
indicate that E-RC1 does not function generally to facili- cal chromatin remodeling activity, a mononucleosomal
tate the interaction of DNA-binding proteins with chro- DNase I footprinting assay was performed (Figure 5A).
matin templates to enable transcriptional activation. In- A rotationally positioned nucleosome was assembled
stead, E-RC1 shows selectivity in the factors and genes by salt dialysis onto a DNA fragment containing a single
that it regulates. Although it is unlikely that E-RC1 is a copy of the sea urchin 5S nucleosome-positioning se-
coactivator only of EKLF, the data suggest that its func- quence. When this positioned nucleosome was digested
tion may be restricted to a specific class of transcrip- with DNase I, a 10 bp repeat ladder was produced (lane
3). In the presence of ATP, E-RC1 was able to remodeltional activators.
b-Globin Chromatin Activation by EKLF and E-RC1
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Figure 4. The EKLF Coactivator E-RC1 Is Identified as a Mammalian SWI/SNF-Related Complex
(A) Diagram of coactivator purification. See Experimental Procedures for details.
(B) Transcriptional activation of chromatin reconstituted b-globin template with EKLF and glycerol gradient fractions of E-RC1. A 13 ml gradient
was divided into 11 fractions from 1 (bottom) to 11 (top). Fifty microliters of each fraction and EKLF protein was added to 1 mg chromatin.
Reactions were then split, and half was DNase I digested and analyzed for hypersensitivity by indirect end-labeling analysis (data not shown).
The remaining chromatin was transcribed. M, MspI-digested pBR322 as a molecular weight marker. Relative fold transcriptional activation is
given under each lane.
(C) SDS-PAGE analysis of E-RC1 glycerol gradient fractions. Ten microliters of each fraction was analyzed by 7.5% SDS-PAGE and visualized
by silver staining. S, DNA±cellulose fraction that was the starting material for glycerol gradients. M, 10 kDa molecular weight markers (GIBCO).
Sedimentation values for standards are shown: thyroglobulin (19.2S), apoferritin (17.6S), b-amylase (11.2S), and bovine serum albumin (4.6S).
The S value for the active complex was calculated from three separate glycerol gradients; the average was 18.7S.
(D) Western blot analysis of glycerol gradient fractions reveals that E-RC1-mediated transcriptional activity comigrates with SWI/SNF subunits.
Ten microliters of each glycerol gradient fraction was electrophoresed on a 7.5% SDS-PAGE and the subunit composition determined by
Western blot analysis. S, 90 mM DNA±cellulose fraction that was the starting material for the gradient. M, ECL markers, sizes indicated.
and disrupt the nucleosome to produce a DNase I diges- a key SWI/SNF subunit of E-RC1 plays a functional role
in EKLF-dependent b-globin transcription.tion pattern intermediate between that of a nucleosome
and free DNA (lanes 7 and 8). In the absence of ATP, no Immunoprecipitations from E-RC1 chromatographic
fractions using antibodies to BAF155 and BAF57 werenucleosome disruption by E-RC1 was observed (lanes
4 and 5). This DNase I pattern is consistent with that carried out to further confirm that E-RC1 is a member
of the mammalian SWI/SNF family. SWI/SNF complexesgenerated by other SWI/SNF±related complexes puri-
fied from both yeast (CoÃ teÂ et al., 1994) and HeLa cells cannot be eluted intact from antibody beads, but they
have been shown to retain activity while on the beads(Kwon et al., 1994).
To confirm the role of one of the SWI/SNF subunits after thorough washing. For example, mammalian SWI/
SNF complexes on beads are able to disrupt mono-in transcription, immunoneutralizations with an antibody
to the HMG domain±containing BAF57 SWI/SNF subunit nucleosomes and facilitate factor binding (Wang et al.,
1996a). As shown in Figure 5C, both BAF57 and BAF155were conducted. As shown in Figure 5B, anti-BAF57
antibody specifically interfered with transcriptional acti- immunoprecipitates were active for DNase I hypersensi-
tive site formation in the presence of EKLF (lanes 5vation, neutralizing 73% of b-globin promoter activity
but not that of a control template (AdLuc) (compare and 17, respectively). A mock immunoprecipitate shows
limited activity (lane 7). From this data, we conclude thatlanes 3 and 4). As controls, preimmune sera and anti-
Rsc6 had no effect (compare lane 4 with 5 and 6). Thus, mammalian SWI/SNF immunoprecipitates from E-RC1
Cell
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Figure 5. Characterization of Purified E-RC1
and Confirmation of the Role of SWI/SNF
Subunits in b-Globin Transcription
(A) Purified E-RC1 possesses classical chro-
matin remodeling activity. DNase I foot-
printing of 5S DNA reconstituted by salt dial-
ysis into a mononucleosome. Following salt
dialysis and sucrose gradient purification,
mononucleosomes were incubated with E-RC1
in either the presence or absence of 1 mM
ATP for 20 min at 278C. Free DNA was di-
gested with 0.005 U DNase I and mono-
nucleosomes with 0.15 U DNase I per reac-
tion. Digestions took place at 278C for 1 min.
Triangles indicate increasing amounts of
E-RC1 (glycerol gradient fraction 4) of 1 ml or
2.5 ml. M, MspI-digested pBR322 as a molec-
ular weight marker.
(B) Immunoneutralizations confirm that BAF57
is an integral component of E-RC1. DNA±
cellulose E-RC1 fraction was incubated with
anti-sera for 30 min on ice prior to addition
to 0.5 mg chromatin template. Relative fold
transcriptional activation is shown under
each lane. Asterisk indicates nonspecific
band. M, MspI-digested pBR322 as a molec-
ular weight marker.
(C) Immunoprecipitations with anti-BAF57
and BAF155 antibodies pull down a complex
sufficient to form a DNase I hypersensitive
site with EKLF in the b-globin promoter.
E-RC1 (DEAE fraction) was used as a source
for either BAF155 or BAF57 immunoprecipita-
tions. The complexes bound to protein A
beads were washed extensively as described
in Experimental Procedures and then added
with EKLF to 0.5 mg chromatin template.
fractions are able to function with the erythroid protein SWI/SNF (BAF) group of chromatin remodeling com-
plexes could replace E-RC1, we obtained SWI/SNF puri-EKLF to alter the chromatin structure of the b-globin
fied from Jurkat T cells, expressing an HA-tagged BAF57promoter. Thus, E-RC1 is a true member of the mamma-
polypeptide (Wang et al., 1998). The activity of this com-lian SWI/SNF group.
plex was measured by a DNase I footprinting analysisBy Western blot analysis, we were able to compare
of a positioned mononucleosome, as in Figure 5A. ThisBAF57 levels in E-RC1 preparations to a titration of bac-
particular SWI/SNF complex cannot substitute for E-RC1terially expressed BAF57 of a known concentration (data
in either EKLF-dependent b-globin transcriptional acti-not shown). One subunit of BAF57 is present in SWI/
vation or in DNase I hypersensitive site formation in theSNF purified from Jurkat T cells that express an HA-
b-globin promoter when used at ratios of up to 1 com-tagged BAF57 (Wang et al., 1998). For the purpose of
plex per 40 nucleosomes (data not shown). When E-RC1
these calculations, we are assuming the same is true of and T cell±derived SWI/SNF are compared on an SDS-
E-RC1. When the DNA±cellulose fraction is used as a PAGE, their subunit compositions appear almost identi-
source of E-RC1, one complex is present for every tem- cal, with some differences in minor bands (Figure 6).
plateÐor, approximately, 1 E-RC1 per 27 nucleosomes. With the exception of the few nonspecific bands in the
Glycerol gradient±purified E-RC1 is used at a ratio of 1 Jurkat SWI/SNF preparation (see Figure 5a; Wang et al.,
complex for every 49 nucleosomes, with comparable 1998), all of the major mammalian SWI/SNF subunits
results for both transcription (Figure 1A) and hypersensi- comigrate with the major polypeptides in purified E-RC1.
tive site formation (data not shown). Although E-RC1 and the T cell±derived SWI/SNF appear
to be functionally distinct, it is important to note thatTo determine whether or not other members of the
b-Globin Chromatin Activation by EKLF and E-RC1
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Southwood, 1995). Two deletion mutants, D20±60 and
D60±196, that remove portions of this core domain are
unable to activate transcription in either transient trans-
fections (Chen and Bieker, 1996) or in our in vitro system
(Figure 8A, compare lane 3 with 4 and 5). Both protein
mutants are able to bind DNA with equal or greater
efficiency than wild-type protein in a DNase I footprinting
analysis of free DNA (Figure 8B). Thus, our E-RC1-
dependent in vitro chromatin transcription assay reflects
genuine transactivation by EKLF.
Although the activation domain of EKLF is required
for transcription of a chromatin-assembled template
(Figure 8A), it is not needed to generate an open pro-
moter conformation. As shown in Figure 8C, both protein
deletion mutants are capable of forming a DNase I hy-
persensitive region (lanes 7±12) that is indistinguishable
from that generated by wild-type protein (lanes 4±6). As
observed with intact EKLF, the deletion mutants are
dependent upon the presence of E-RC1 for hypersensi-
tive site formation, as they cannot function alone (data
not shown). Thus, the activation domain of EKLF must
function at a step subsequent to the generation of anFigure 6. SDS-PAGE Analysis Comparing Purified E-RC1 with Jur-
kat T Cell SWI/SNF open chromatin structure at the promoter. The b-thalas-
Equal amounts of each complex were electrophoresed on a 7.5% semia 287 point mutant promoter, which is not bound
SDS-PAGE and visualized by silver staining. M, 10 kDa protein mo- by EKLF, was also assayed for hypersensitive site for-
lecular weight markers (GIBCO) with sizes indicated. BAF subunits mation. These studies indicate that the mutant b-globin
are identified at the right. Nonspecific bands resulting from HA-
promoter is transcriptionally inert as a result of a closedimmunopurification of T cell SWI/SNF are indicated by asterisks.
chromatin conformation that is shown by a reduction in
DNase I hypersensitivity (Figure 8C, lanes 16±18). From
these data, we conclude that EKLF binding, in combina-
other SWI/SNF family members may share the same tion with E-RC1, is necessary for an open chromatin
characteristics as E-RC1, and the ability to activate tran- configuration within the b-globin promoter.
scription by EKLF may be a general property of SWI/
SNF complexes.
Discussion
E-RC1-Dependent b-Globin Promoter Activation
Requires an Intact 290 EKLF-Binding We have reproduced stage-specific activation of a chro-
Site and EKLF Activation Domain matin-assembled human b-globin promoter in vitro. We
Many b-thalessemias are caused by mutations within find that chromatin remodeling and transcriptional activ-
the b-globin locus. One such point mutation occurs ity are dependent upon both the erythroid KruÈ ppel-like
within the 290 EKLF-binding site of the b-globin pro- factor (EKLF) and a SWI/SNF complex, E-RC1. This dem-
moter at 287 (C to G) (Orkin et al., 1982), which ef- onstrates that a member of the mammalian SWI/SNF
fectively eliminates EKLF binding and transactivation (BAF) family of complexes can regulate transcription of
(Feng et al., 1994). The reduction of b-globin expression a chromatin template in vitro. Furthermore, our analyses
seen in b-thalessemia patients has been reproduced in provide insight into the specific mechanisms by which
our in vitro system using chromatin-reconstituted tem- the critical erythroid factor EKLF functions within chro-
plates. As shown in Figure 7A, the chromatin-assembled matin.
mutant b-globin promoter is not competent for tran-
scriptional activation by EKLF and E-RC1 (compare lanes
5 and 6 with 13 and 14). However, both wild-type and Possible Mechanism of Action
of SWI/SNF±Related E-RC1mutant promoters transcribe with equal efficiency as
free DNA (Figure 7B). A DNase I footprint analysis con- Our studies reveal that EKLF is dependent upon E-RC1
for the formation of an open, poised promoter. Severalfirms that EKLF is unable to bind the mutant site (Figure
7C, compare lanes 2 and 3 with 5 and 6). Therefore, potential mechanisms of action exist. EKLF may first
bind its site within the promoter and identify nearbyEKLF must bind to its site at 290 to function as an
activator of a chromatin-assembled promoter, and its nucleosomes as a target for E-RC1 activity. Yeast SWI/
SNF has been shown to act transiently to disrupt aregulatory effects are more pronounced in a chromatin
environment than as free DNA. nucleosome marked by GAL4±AH binding (Owen-Hughes
et al., 1996). E-RC1 may also function to promote EKLFEKLF contains an N-terminal proline-rich activation
region, with the minimal activation domain extending nucleosomal interaction, since yeast SWI/SNF enhances
nucleosomal binding of several transcription factors, in-from amino acids 20 to 124. This domain is essential
for transactivation in transient transfections (Bieker and cluding GAL4 derivatives (CoÃ teÂ et al., 1994; Kwon et
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Figure 7. A b-Globin Promoter Containing a Naturally Occurring b-Thalassemia Point Mutation in the 290 EKLF Site Is Not Transcriptionally
Activated by EKLF and E-RC1
(A) Transcription of chromatin-assembled b-globin templates. One microgram template, containing either wild-type or mutant promoter, was
incubated with E-RC1 (DEAE fraction) and/or EKLF protein as indicated. In this case, E-RC1 and EKLF protein were incubated with the
template throughout chromatin assembly; the results are not affected as a result of the change in the time of factor addition. The sequence
of the wild-type and mutant EKLF sites are shown.
(B) The EKLF mutant b-thalessemia promoter is readily transcribed as free DNA. One microgram template was carried through a mock
chromatin-assembly protocol, with buffers substituting for the chromatin-assembly extract and histones. M, MspI-digested pBR322 as a
molecular weight marker.
(C) DNase I footprint analysis of wild type and mutant b-globin promoters. DNA fragments spanning 2170 to 23, from either the wild-type or
287 point mutant promoter, were generated by PCR and footprinted with 7.5 pmol or 15 pmol EKLF as indicated by triangles. The EKLF
DNA-binding site is marked by brackets.
al., 1994), TATA-binding protein (TBP) (Imbalzano et al., even when prebound to the template (data not shown),
suggesting that E-RC1 is functioning at a step subse-1994), Sp1, USF, and NF-KB (Utley et al., 1997).
Studies both in vitro and in vivo suggest that SWI/ quent to factor binding.
Further studies are necessary to address whether orSNF functions to assist transcription factors that have
difficulty accessing their binding sites. In vitro, multimer- not EKLF directly interacts with E-RC1 to recruit the
complex to the b-globin promoter. A preliminary analysisized factor binding sites enhanced nucleosomal interac-
tion by a transcriptional activator and lowered the stimu- of EKLF deletion mutants indicates that the C-terminal
zinc fingers are a potential site for interaction (data notlatory effect of SWI/SNF (Utley et al., 1997). In vivo, GAL4
is dependent upon SWI/SNF to function at low-, but not shown). SWI/SNF increases transcriptional activation by
the glucocorticoid receptor and the estrogen receptorhigh-, affinity GAL4 sites (Burns and Peterson, 1997). In
the case of the human b-globin promoter, the initial when assayed in yeast, and SWI3 is coimmunoprecipi-
DNase I resistant structure indicated that a majority of tated with a 150-amino-acid fragment centered on the
templates are likely to have a nucleosome located at zinc finger region of the glucocorticoid receptor (Yoshi-
the 290 EKLF site. E-RC1 may enhance EKLF binding naga et al., 1992).
to its nucleosomal site in addition to promoting nucleo-
some perturbation. Many transcription factors can be
Transcriptional Activation of the b-Globin Promoterprebound to templates prior to chromatin formation. In
Once the promoter resides in an open chromatin config-this way, they presumably bypass the requirement of
uration, transcriptional activation can occur. Althoughany complexes that would facilitate their binding to a
the EKLF activation domain does not play a role in hyper-nucleosomal site. However, EKLF cannot activate tran-
scription or remodel chromatin in the absence of E-RC1 sensitive site formation, it is critical at this stage. Our
b-Globin Chromatin Activation by EKLF and E-RC1
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Figure 8. The Proline-Rich Activation Domain of EKLF Is Necessary for Transcriptional Activation
(A) Transcription of chromatin-assembled b-globin template is only observed with a complete EKLF activation domain. Chromatin was
incubated with DNA±cellulose E-RC1 fraction and either wild-type or mutant EKLF protein as indicated. M, MspI-digested pBR322 as a
molecular weight marker. EKLF protein domains are shown below.
(B) DNA footprint of b-globin promoter with EKLF mutants lacking the activation domain. PCR-generated fragment from 2170 to 23 of the
b-globin promoter was incubated with 3 pmol protein or 7.5 pmol protein as indicated by triangles. The EKLF site is shown by brackets.
(C) DNase I hypersensitive site formation within the b-globin promoter is dependent on an intact 290 CACCC element and is independent of
an EKLF activation domain. Indirect end-labeling of DNase I digested chromatin. Chromatin templates containing either the wild-type promoter
(lanes 1±12) or the 287 point mutant (lanes 13±21) were incubated with DNA±cellulose E-RC1 fraction and wild-type or mutant EKLF protein
as shown. Reactions were then split, and half was transcribed as a control (data not shown). The remaining chromatin was divided into three
tubes with 150 ng chromatin per tube and digested with 1.5, 2, or 3 U of DNase I. Triangles indicate increasing amounts of DNase I. Brackets
show the 2120 to 110 region of the promoter. M, digested b-globin plasmid as a size marker.
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results are in agreement with previous studies that indi- Implications for b-Globin Gene Locus Regulation
The b-globin locus is an ideal model system for thecated that the proline-rich activation domain is required
for erythroid cell±specific activation of the b-globin gene exploration of the interdependence of tissue- and stage-
specific expression with precise chromatin structures.(Bieker and Southwood, 1995). The proline-rich domain
of the transcriptional activator CTF1 has been shown to Our identification of an EKLF coactivator as a member
of the SWI/SNF (BAF) family of chromatin remodelingbind TFIIB and facilitate its recruitment to a TBP±DNA
complex (Kim and Roeder, 1994). Likewise, the activa- complexes provides further evidence for that relation-
ship. In addition to its role in the b-globin promoter,tion domain of EKLF may target a component of the
RNA polymerase II machinery. Our findings are consis- EKLF is necessary for the formation of hypersensitive
site 3 (HS3) within the locus control region (LCR) (Wij-tent with studies of GAL4±VP16 (Pazin et al., 1994) and
the thyroid hormone receptor (Wong et al., 1997) that gerde, et al. 1996). Further efforts are underway to eluci-
date the role of E-RC1 in EKLF-mediated chromatin re-maintained that disruption of the chromatin structure of
a promoter may occur in the absence of an activation modeling of the LCR and LCR promoter communication
within the b-globin gene locus.domain but is not, in itself, sufficient to allow transcrip-
tion. Gene activation in the context of chromatin has
recently been reviewed (Armstrong and Emerson, 1998;
Experimental Procedures
Cairns, 1998; Kadonaga, 1998).
Plasmid Constructions
bCAT plasmid was constructed as described (Jane et al., 1992).
Full-length EKLF was cloned into the NdeI and BamHI sites of theFunctional Selectivity of Chromatin
pET-14b bacterial expression vector (Novagen). EKLFD20±60 wasRemodeling Complexes
generated after ApaI restriction to remove the amino terminus.A fascinating issue that will no doubt be the focus of
EKLFD60±196 was made by digestion with ApaI and SacII and reli-much study in the future is, how prevalent is functional
gated.
selectivity among chromatin remodeling complexes?
Mammalian SWI/SNF family members are more diverse
Protein Purificationand heterogeneous than the yeast version, suggesting
Histidine-tagged wild-type and mutant EKLF proteins were ex-
that different complexes may play distinct roles in the pressed in E. coli BL21(DE3)pLysS or BL21(DE3) cells. All proteins
cell (Wang et al., 1996a, 1996b). E-RC1 shows selectivity were purified under denaturing conditions on Ni21-NTA resin (Qia-
by facilitating EKLF-dependent b-globin transcription gen) and then renatured by step dialysis.
MEL (mouse erythroleukemia) cells were grown and the proteinbut not TFE-3-dependent HIV-1 expression, even though
extracts prepared as previously described (Armstrong and Emerson,it remodels nucleosomes nonspecifically (Figure 5A).
1996). All purification steps were performed at 48C. For E-RC1 purifi-Other members of the SWI/SNF family may also share
cation, approximately 120 mg protein were loaded onto phosphocel-
this property and the ability to function with EKLF. Selec- lulose P-11 resin (Whatman), 8±10 ml bed volume, equilibrated in
tivity of transcription factor interaction may, in fact, ex- 0.1 M KCl P-11 buffer (20 mM HEPES [pH 7.9], 20% glycerol, 0.2
plain why yeast SWI/SNF regulates only a subset of mM EDTA, 2 mM DTT). The column was washed with 0.1 M KCl
P-11 buffer. Step elutions of 0.3 M KCl, 0.6 M KCl, and 1.0 M KClgenes in vivo (reviewed in Winston and Carlson, 1992).
were collected. E-RC1 eluted in the 0.6 M KCl peak, which wasMultiple chromatin modifying activities are also pres-
dialyzed into dialysis buffer (20 mM HEPES [pH 7.9], 50 mM KCl,ent in the Drosophila assembly extracts used in our
0.2 mM EDTA, 10% glycerol, 2 mM DTT). E-RC1 was then loaded
experiments. These include NURF (Tsukiyama and Wu, onto a DEAE-sephacel (Pharmacia) column equilibrated in dialysis
1995), ACF (Ito et al., 1997), and CHRAC (Varga-Weisz buffer. After washing, E-RC1 was eluted with dialysis buffer con-
et al., 1997). Both ACF and NURF have been shown to taining 0.25 M KCl and dialyzed into dialysis buffer. The 0.25 M
DEAE fraction was loaded on a dsDNA±cellulose (Sigma) columnpotentiate transcriptional activation in vitro (Ito et al.,
equilibrated in DNA±cellulose buffer (20 mM HEPES [pH 7.9], 5 mM1997; Mizuguchi et al., 1997). We cannot rule out the
MgCl2, 10% glycerol, 0.1% Brij-35, 1 mM DTT) containing 25 mMpossibility that these or other complexes present in the
ammonium sulfate. After extensive washing, E-RC1 was eluted with
Drosophila extracts are contributing to the transcription DNA±cellulose buffer containing 90 mM ammonium sulfate and dia-
we observe. However, since purified E-RC1 is absolutely lyzed into DNA±cellulose dialysis buffer (20 mM HEPES [pH 7.9],
required for transcriptional activation and chromatin dis- 100 mM KCl, 3 mM MgCl2, 0.2 mM EDTA, 20% glycerol, 0.1% NP-
40, 0.5 mM DTT). The 90 mM DNA±cellulose fraction was appliedruption, these complexes are not sufficient to function
to a 13 ml 20%±35% glycerol gradient, approximately 320 mg proteinwith EKLF. By contrast, another hematopoietic factor,
per gradient, and centrifuged in an SW41 rotor at 29,000 rpm for 24NF-E2, does not require an exogenous SWI/SNF chro-
hr. Glycerol gradients were prepared in DNA±cellulose dialysis buffer
matin remodeling activity but can cooperate with those except that NP-40 was omitted. Gradients were divided into 11
complexes present in Drosophila extracts to reconfigure fractions that were dialyzed separately into dialysis buffer.
the LCR/HS2 enhancer (Armstrong and Emerson, 1996).
We believe that the observation that EKLF, TFE-3, and
Chromatin Assembly and Transcription Reactions
NF-E2 appear to function with distinct chromatin modi- Chromatin was reconstituted as described (Armstrong and Emer-
fying activities is relevant. EKLF demonstrates a prefer- son, 1996). Following assembly, the chromatin template (1 mg in
100 ml) was incubated with wild-type or mutant EKLF protein (37ence for a SWI/SNF remodeling complex, and this type
pmol each) and E-RC1 fractions, as described in the figure legends,of specificity may play a role in many instances of highly
for 20 min at 278C. The reactions were then split for either transcrip-regulated transcription. The erythroid-specific EKLF is
tion or structural analysis. To allow transcription, 25 ml nuclear HeLathe founding member of a family of KruÈ ppel-like factors extract (typically about 8 mg/ml), prepared as described (Dignam
with similar zinc-finger domains. It will be exciting to et al., 1983), was added to 0.5 mg of chromatin and incubated on
pursue whether these family members also show a func- ice for 10 min. Transcription mix was added (20 mM HEPES [pH
7.9], 50 mM KCl, 5 mM MgCl2, 0.2 mg/ml BSA, 0.5 mM [each] ATP,tional requirement for E-RC1.
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CTP, UTP, GTP, 0.7 mg/ml Adeno-luciferase control template [Ad- Schulz for helpful discussions and a critical reading of this manu-
script. This work was supported by Grant GM 38760 from the Na-Luc], 1 mM DTT) in a final volume of 150 ml. Transcription proceeded
at 308C for 30 min and was stopped by the addition of 250 ml of tional Institutes of Health (B. M. E.) and a scholarship from the
Leukemia Society of America (J. J. B.).transcription stop buffer (1% SDS, 20 mM EDTA). The purified RNA
product was analyzed by primer extension analysis.
Received April 2, 1998; revised August 13, 1998.
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